Who are smallpox vaccine CJ-50300's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Smallpox and Mpox Vaccine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/smallpox-vaccine-cj-50300.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

smallpox vaccine CJ-50300 — Competitive Intelligence Brief

smallpox vaccine CJ-50300 (smallpox vaccine CJ-50300) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Recombinant viral vaccine. Area: Immunology.

phase 3 Recombinant viral vaccine Immunology Small molecule Live · refreshed every 30 min

Target snapshot

smallpox vaccine CJ-50300 (smallpox vaccine CJ-50300) — Seoul National University Hospital. CJ-50300 is a recombinant vaccinia virus-based vaccine designed to induce immune responses against smallpox virus antigens.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
smallpox vaccine CJ-50300 TARGET	smallpox vaccine CJ-50300	Seoul National University Hospital	phase 3	Recombinant viral vaccine
Smallpox and Mpox Vaccine	Smallpox and Mpox Vaccine	SIGA Technologies	marketed	Live attenuated viral vaccine / Recombinant viral vaccine

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Recombinant viral vaccine class)

Seoul National University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). smallpox vaccine CJ-50300 — Competitive Intelligence Brief. https://druglandscape.com/ci/smallpox-vaccine-cj-50300. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab